NPAT for stage 1 is around $9m p.a.
Assume a 10x multiple (LOM for stage 1 is 100's of years) and you get a $90m val. If all debt funded this should trade at 7.8c. If converse and fully equity funded then it should trade at something like 3.4c. I would be looking for a base case something like 60/40 debt/equity and as such a valuation of something like 6c on stage 1 alone. Discount for risk that still applies to DFS, offtakes, actually getting the debt funding etc. But then add in a risked valuation for stage 2 etc.
IMO only this is still at least 100% undervalued for where they are currently, particularly remembering they have $6.5m in cash at current.
- Forums
- ASX - By Stock
- Ann: Strategic Partnership Agreement For Development Of Siviour
NPAT for stage 1 is around $9m p.a. Assume a 10x multiple (LOM...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNU (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $223.6M |
Open | High | Low | Value | Volume |
8.8¢ | 8.9¢ | 8.6¢ | $171.8K | 1.969M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 459444 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 1365 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 459444 | 0.086 |
29 | 1483543 | 0.085 |
15 | 378744 | 0.084 |
12 | 539197 | 0.083 |
7 | 949050 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 1365 | 1 |
0.089 | 671202 | 9 |
0.090 | 1159863 | 6 |
0.091 | 103898 | 2 |
0.092 | 9350 | 2 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
RNU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online